JESSICA BOLDEN: Open Payments
NPI 1144754680 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,918 in 118 payments from 23 companies in 2025. Trend: 2023 $1,789 · 2024 $2,192 · 2025 $1,918
Food & beverage: $1,918
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $344 |
| Novo Nordisk Inc | 21 | $291 |
| Lilly USA, LLC | 15 | $217 |
| AstraZeneca Pharmaceuticals LP | 9 | $194 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $164 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| Corcept Therapeutics | 5 | $78 |
| PFIZER INC. | 4 | $72 |
| Janssen Pharmaceuticals, Inc | 2 | $52 |
| Exact Sciences Corporation | 3 | $49 |
Products named: UBRELVY, MOUNJARO, Kerendia, Ozempic, VRAYLAR, FARXIGA, LEQVIO, Rybelsus.
Industry payments across SC — which companies pay providers there.
